Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia

This study signifies the critical consequences of developmental timing in cancer initiation, revealing that identical driver mutations in fetal- versus postnatal-origin leukemias exhibit fundamentally distinct biology and treatment responses. Recognizing these developmental differences opens avenues for personalized therapeutic strategies, improving outcomes for pediatric patients with aggressive disease subtypes in leukemia.

Authors

Institutions

Publication Details

Journal
Cancer Discovery
Published
2025-12-06
DOI
https://doi.org/10.1158/2159-8290.cd-25-0556
Citations
1
Primary Topic
Acute Lymphoblastic Leukemia research
Type
article
Field-Weighted Citation Impact
1.88
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia

Eric So, Meghana Sreenath, Jennifer C. Dempsey, Kimberly A. Aldinger et al.
1 citations
Cancer Discovery
Acute Lymphoblastic Leukemia research
1.88
article

Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia

Eric So, Meghana Sreenath, Jennifer C. Dempsey, Kimberly A. Aldinger, Noelle Wheeler, Julie A. Reisz, Mark Wunderlich, Jerry E. Chipuk, Rhonda E. Ries, Mirela Berisa, Bridget Kelly Marcellino, Levan Mekerishvili, Franco Izzo, Giang T. Pham, Persephone Fiore, Angelo D’Alessandro, Daniel J. Puleston, Zayna Diaz, Dan Filipescu, Soheil Meshinchi, Ian G. Phelps, Emily Bernstein, Eirini P. Papapetrou, Elvin Wagenblast, Tommaso Balestra, Dan Doherty, Sarah K. Tasian, Miguel Quijada‐Álamo, Nikita Poddar, Saul Carcamo, Shayan Saniei, Ian A. Glass, Christopher M. Sturgeon, Subrina Persaud, Dan A. Landau, Jing Zhang, Zhihong Chen, Mimi Zhang, Dan Hasson, Grace S. Freed, Maria Gracia Gonzalez, Noshin Azra Rahman, C. Chao, Jack H. Peplinski, Isabella G. Martinez, Anna Mei, Ke Wang, Katherine Lachman, Yasmeen Otaibi
article en
1 citations

Abstract

This study signifies the critical consequences of developmental timing in cancer initiation, revealing that identical driver mutations in fetal- versus postnatal-origin leukemias exhibit fundamentally distinct biology and treatment responses. Recognizing these developmental differences opens avenues for personalized therapeutic strategies, improving outcomes for pediatric patients with aggressive disease subtypes in leukemia.

Cancer DiscoveryVol. 16(3)
Cincinnati Children's Hospital Medical Center (US), Children's Hospital of Philadelphia (US), University of Washington (US), Cornell University (US), Fred Hutch Cancer Center (US), Mount Sinai Medical Center (US), Child Health and Development Institute (US), New York Genome Center (US), University of Colorado Anschutz Medical Campus (US), University of Pennsylvania (US), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 10%
Acute Lymphoblastic Leukemia research
1.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.